Status:
COMPLETED
Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a French Multicenter Study
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Apheresis Related Complication
Eligibility:
All Genders
Up to 18 years
Brief Summary
After developing in pediatric hematology and nephrology, therapeutic apheresis is increasingly used in pediatric neurology despite a sparse level of evidence. There are a few retrospective series wit...
Detailed Description
Multicenter medical data collection : * Montpellier * Toulouse * Bordeaux * Marseille * Nancy * Paris Kremlin Bicêtre * Paris Robert Debré * Paris Necker * Paris Trousseau * Lyon * Besançon * Rennes ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Children under 18.
- Supported in a participating CHU between 2014 and 2019.
- Having benefited from therapeutic apheresis (plasma exchanges and immunoadsorption) in a neuropediatric indication
- Exclusion criteria:
- \- Family or patient refusal to participate
Exclusion
Key Trial Info
Start Date :
February 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04845516
Start Date
February 15 2021
End Date
December 31 2021
Last Update
April 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295